Latest News

Launch of Novodiag® Bacterial GE+, a new diagnostic test for on-demand detection of bacterial pathogens



Published on 17 Apr 2018



Share on

Espoo, Finland, April 17th, 2018 Mobidiag today announced the launch of Novodiag® Bacterial GE+, a molecular diagnostic test for the simultaneous detection of most common enteric pathogens directly from stool samples. Compatible with the fully automated Novodiag® system launched at the end of 2017, this new disposable cartridge allows direct analysis of a patient sample and delivers comprehensive results in about an hour, compared to days with currently used culture methods.

 

“The new Novodiag Bacterial GE+ cartridge can identify dozens of targets, including the majority of bacteria causing diarrhea. Thanks to its simplified and optimized workflow, our fully automated Novodiag solution can support early decision making prior to any treatment delivery and improve patient care by managing infections accordingly” explains Tuomas Tenkanen. “We are very proud to now offer the first syndromic test compatible with our Novodiag system. Our ambition is to make accessible one of the most relevant range of test panels. We are currently working on extending our product line and address among others the detection of antibiotic resistances to improve the correct use of antibiotics”.

 

Novodiag® Bacterial GE+ test is now available directly through Mobidiag and local distributors. For more information, visit our product page.

 

About Novodiag® (CE-IVD)

The Novodiag solution allows direct analysis of a patient sample placed in a disposable cartridge and delivers comprehensive results in about an hour. Combining qPCR and microarray technologies, Novodiag offers an all in one solution for on-demand targeted and syndromic testing.

This molecular diagnostic solution offers an easy to use and cost-efficient method, with very limited hands-on-time and without the need for much technical expertise. Novodiag is suitable for all test volumes and on demand testing for clinical laboratories.

Learn more about Novodiag.

Do not hesitate to contact us for more information.

 

See full press release in English.

See full press release in French.



© Copyright Mobidiag Ltd. All Rights Reserved. Learn more about our Privacy policy.